Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Jun 28, 2021 5:43pm
217 Views
Post# 33463680

RE:The value of the paper is quite evident

RE:The value of the paper is quite evident...to everyone except to most analysts, most institutions, and most investors on both sides of the border.

I wonder if the PMX tire kickers know about Dialco and the FDA approved SAMI and the partially approved DIMI, and if the Dialco tire kickers know about the PMX,phase 3b confirmatory Trial, with favourable carryforwards from Euphrates and the FDA approved companion diagnostic?

This is unlike a two trick pony - where you can only sell the pony to one buyer.  This is really two ponies and possibly (likely) two different future owners. (it'll be  a bit sad to break them up)

Given the limited number of potential sideshow buyers (of each pony) perhaps there are only two marketing strategies:

1. Excite the public about what is coming to a carnival near them, your ponies and their amazing never before seen tricks.  That in turn, will allow the Sideshow owners to gauge the public's appetite for the ponies, and perhaps entice them to outbid each other for one or more of the respective ponies? 

2. Keep your ponies under wraps (away from the eyes of the public) - until the last possible minute, when you have two Sideshow buyers on the hook. Pray one of your ponies doesn't get ill or break a leg in the meantime. Or that the market for circus acts doesn't dry up altogether. And that you have maximized the value that can be derived from each pony.

MM


<< Previous
Bullboard Posts
Next >>